The new financing package is divided into two distinct components: a C$25 million revolving facility with a three-year maturity and a C$15 million delayed draw term loan. High Tide plans to utilize the revolving portion to refinance its current debt with connectFirst and provide liquidity for general corporate requirements, including future acquisitions. The term loan is specifically earmarked to replace the company’s existing second-lien debentures.

Raj Grover, founder and CEO of High Tide, described the deal as a defining milestone for the enterprise. According to Grover, the facility provides the company with more efficient capital as it enters its next phase of growth. Final closing of the agreement remains subject to customary conditions, with the company expecting to finalize the transaction within approximately 30 days. High Tide currently operates the Canna Cabana retail network and maintains a significant footprint in the German medical cannabis market through its subsidiary, Remexian Pharma GmbH.